tisagenlecleucel in pediatric r/r b-cell all
Published 4 years ago • 147 plays • Length 7:41Download video MP4
Download video MP3
Similar videos
-
2:48
out of specification tisagenlecleucel in real-world treatment of pediatric b-all
-
2:18
analysis of real-world outcomes in patients with b-all receiving tisagenlecleucel
-
6:07
novel prognostic index for pediatric all
-
5:19
circulating micrornas as mrd biomarkers in pediatric all
-
8:57
outcomes of sct in t-all and t-lbl
-
9:25
mgus diagnosis: a step-by-step approach
-
5:13
what is a haematologist?
-
4:22
discover versiti diagnostic labs, clinical trials and biomaterials | versiti
-
0:56
microbiota in hematologic malignancies
-
0:32
patient selection for ctcl
-
5:13
ukall2011: abl-class fusions & tkis
-
2:05
results from the phase i sal-relax trial: venetoclax plus cytarabine and mitoxantrone in r/r aml
-
5:08
insights into the tarmac study: time-limited ibrutinib and tisa-cel in patients with r/r mcl
-
0:49
the future of inhibiting bcl2 for the treatment of t-all
-
8:34
hct in mds: cell source and conditioning type
-
1:53
the future of multiple myeloma treatment
-
1:20
regulation of tetraspanin cd63 in cml progression: single-cell analysis of asymmetric hsc division
-
5:18
upfront treatment in transplant candidates
-
1:16
eha/ebmt consensus grading of icaht
-
2:09
heart transplantation in attr amyloidosis
-
2:21
an update from limber-104: zilurgisertib /- ruxolitinib in the management of mf-associated anemia